Showing 1 - 20 results of 22 for search 'René Olivier', query time: 0.06s
Refine Results
-
1
-
2
The Rare Cancer Network: achievements from 1993 to 2012 by Kenneth Chang, Robert Clell Miller, Sumita Bhatia, Rene-Olivier Mirimanoff, Mahmut Ozsahin, Ajaykumar Patel
Published 2012-06-01
Article -
3
-
4
-
5
-
6
Prognostic factors in adult soft tissue sarcoma treated with surgery combined with radiotherapy: a retrospective single-center study on 164 patients by Ling Cai, René-Olivier Mirimanoff, Elyazid Mouhsine, Louis Guillou, Pierre-Francois Leyvraz, Serge Leyvraz, Beatrice Gay, Oscar Matzinger, Mahmut Ozsahin, Abderrahim Zouhair
Published 2013-10-01
Article -
7
Influence of Sociodemographic Determinants on the Hodgkin Lymphoma Baseline Characteristics in Long Survivors Patients Enrolled in the Prospective Phase 3 Trial AHL2011 by Steeve Chevreux, Sandra de Barros, Camille Laurent, Amandine Durand, Cyrille Delpierre, Philippine Robert, Clémentine Joubert, Samuel Griolet, Salim Kanoun, Jean-Noël Bastie, René-Olivier Casasnovas, Cédric Rossi
Published 2022-12-01
Article -
8
Risk Factors of Progression in Low-tumor Burden Follicular Lymphoma Initially Managed by Watch and Wait in the Era of PET and Rituximab by Cyrielle Rodier, Lukshe Kanagaratnam, David Morland, Adélie Herbin, Amandine Durand, Adrien Chauchet, Sylvain Choquet, Philippe Colin, René Olivier Casasnovas, Eric Deconinck, François Godard, Alain Delmer, Cédric Rossi, Eric Durot
Published 2023-05-01
Article -
9
P1090: LONG TERM FOLLOW-UP OF UNTREATED/RELAPSING MCL PATIENTS WITH THE IBRUTINIB, OBINUTUZUMAB, AND VENETOCLAX COMBINATION. by Steven Le Gouill, Franck Morschhauser, David Chiron, Kamal Bouabdallah, Guillaume Cartron, Rene Olivier Casasnovas, Caroline Milin, Charles Herbaux, Emmanuelle Tchernonog, Cedric Rossi, Simon Rule, Thomas Gastinne, Mary Callanan, Benoit Tessoulin
Published 2023-08-01
Article -
10
Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study by Raphaël Busson, Marleen van der Kaaij, Nicolas Mounier, Berthe M. P. Aleman, Catherine Thiéblemont, Aspasia Stamatoullas, Vincent Ribrag, Hervé Tilly, Corinne Haioun, René-Olivier Casasnovas, Hanneke C. Kluin-Nelemans, Michel Henry-Amar
Published 2019-07-01
Article -
11
History of the Rare Cancer Network and past research by René-Olivier Mirimanoff, Mahmut Ozsahin, Juliette Thariat, Enis Ozyar, Ulrike Schick, Berrin Pehlivan, Marco Krengli, Alessandra Franzetti Pellanda, Hansjörg Vees, Ling Cai, Luciano Scandolaro, Yazid Belkacemi, Salvador Villà, Sefik Igdem, Myroslav Lutsyk, Robert C. Miller
Published 2014-08-01
Article -
12
Primary breast lymphoma: Patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study by Gutiérrez Cristina, Maingon Philippe, Scalliet Pierre, Nguyen Tan, Belkacémi Yazid, Villette Sylviane, Amsler Beat, Zwahlen Daniel, Poortmans Philip, Epelbaum Ron, Taghian Alphonse, Jeanneret-Sozzi Wendy, Gastelblum Pauline, Krengli Marco, Raad Rita, Ozsahin Mahmut, Mirimanoff René-Olivier
Published 2008-04-01
Article -
13
Outcomes of preoperative chemoradiotherapy followed by surgery in patients with unresectable locally advanced sigmoid colon cancer by Bo Qiu, Pei-Rong Ding, Ling Cai, Wei-Wei Xiao, Zhi-Fan Zeng, Gong Chen, Zhen-Hai Lu, Li-Ren Li, Xiao-Jun Wu, Rene-Olivier Mirimanoff, Zhi-Zhong Pan, Rui-Hua Xu, Yuan-Hong Gao
Published 2016-07-01
Article -
14
The Rare Cancer Network: ongoing studies and future strategy by Mahmut Ozsahin, René-Olivier Mirimanoff, Juliett Thariat, Xu Shan Sun, Banu Atalar, Yasmin Lassen-Ramshad, Gamze Ugurluer, Sunil Krishnan, Christopher Hallemeier, Paul Van Houtte, Marco Krengli, Lan Jun Zhang, Kenneth Chang, Ryan Funk, Jessica Rooney, Robert Miller
Published 2014-08-01
Article -
15
P1079: VERY LONG-TERM FOLLOW-UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY. by Clementine Sarkozy, Catherine Thieblemont, Lucie Oberic, Anne Moreau, Kamal Bouabdallah, Gandhi Laurent Damaj, Thomas Gastinne, Vincent Ribrag, Rene Olivier Casasnovas, Corinne Haioun, Roch Houot, Fabrice Jardin, Eric Van Den Neste, Morgane Cheminant, Franck Morschhauser, Mary Callanan, Herve Ghesquieres, Remy Gressin, Olivier Hermine, Steven Le Gouill
Published 2023-08-01
Article -
16
P1146: TRANSFUSION NEEDS AFTER CD19 CAR T-CELLS FOR LARGE B-CELL LYMPHOMA: PREDICTIVE FACTORS AND IMPACT ON OUTCOME. A DESCAR-T STUDY. by Samuel Vic, Jean-Baptiste Thibert, Emmanuel Bachy, Guillaume Cartron, Thomas Gastinne, Ibrahim Yakoub-Agha, Fabien Le Bras, Kamal Bouabdallah, Fabien Despas, Jacques Olivier Bay, Marie-Thérèse Rubio, Mohamad Mohty, Rene Olivier Casasnovas, Sylvain Choquet, Cristina Castilla-Llorente, Stephanie Guidez, Michael Loschi, Blandine Guffroy, Sylvain Carras, Laurianne Drieu La Rochelle, Roch Houot
Published 2023-08-01
Article -
17
Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years by Maxime Jullien, Benoit Tessoulin, Hervé Ghesquières, Lucie Oberic, Franck Morschhauser, Hervé Tilly, Vincent Ribrag, Thierry Lamy, Catherine Thieblemont, Bruno Villemagne, Rémy Gressin, Kamal Bouabdallah, Corinne Haioun, Gandhi Damaj, Luc-Matthieu Fornecker, Jean-Marc Schiano De Colella, Pierre Feugier, Olivier Hermine, Guillaume Cartron, Christophe Bonnet, Marc André, Clément Bailly, René-Olivier Casasnovas, Steven Le Gouill
Published 2021-09-01
Article -
18
S233: AXICABTAGENE CILOLEUCEL AS SECOND-LINE THERAPY FOR LARGE B-CELL LYMPHOMA IN TRANSPLANT-INELIGIBLE PATIENTS: FINAL ANALYSIS OF ALYCANTE, A PHASE 2 LYSA STUDY by Roch Houot, Emmanuel Bachy, Guillaume Cartron, Francois-Xavier Gros, Franck Morschhauser, Lucie Oberic, Thomas Gastinne, Pierre Feugier, Rémy Duléry, Catherine Thieblemont, Magalie Joris, Fabrice Jardin, Sylvain Choquet, Rene Olivier Casasnovas, Gabriel Brisou, Morgane Cheminant, Jacques Olivier Bay, Francisco Llamas, Cedric Menard, Karin Tarte, Marie-Helene Delfau-Larue, Emmanuel Itti, Clément Bailly, Yassine Al Tabaa, Camille Laurent, Francois Lemonnier
Published 2023-08-01
Article -
19
The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study by Josée M. Zijlstra, George Follows, Rene-Olivier Casasnovas, Joost S. P. Vermaat, Nagesh Kalakonda, Sylvain Choquet, Brian Hill, Catherine Thieblemont, Federica Cavallo, Fatima De la Cruz, John Kuruvilla, Nada Hamad, Ulrich Jaeger, Paolo Caimi, Ronit Gurion, Krzysztof Warzocha, Sameer Bakhshi, Juan-Manuel Sancho, Michael Schuster, Miklos Egyed, Fritz Offner, Theodoros P. Vassilakopoulos, Priyanka Samal, Matthew Ku, Jenny Xu, Kelly Corona, Kamal Chamoun, Jatin Shah, Miguel Canales, Marie Maerevoet
Published 2022-02-01
Article -
20
Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell Lymphoma by Simon Le Gallou, Simon Le Gallou, Faustine Lhomme, Faustine Lhomme, Jonathan M. Irish, Jonathan M. Irish, Anna Mingam, Celine Pangault, Celine Pangault, Celine Monvoisin, Juliette Ferrant, Imane Azzaoui, Delphine Rossille, Delphine Rossille, Krimo Bouabdallah, Gandhi Damaj, Guillaume Cartron, Pascal Godmer, Steven Le Gouill, René-Olivier Casasnovas, Thierry Jo Molina, Roch Houot, Roch Houot, Thierry Lamy, Thierry Lamy, Karin Tarte, Karin Tarte, Thierry Fest, Thierry Fest, Mikael Roussel, Mikael Roussel
Published 2021-12-01
Article